Regulated localization of an AID complex with E2A, PAX5 and IRF4 at the Igh locus.
Introduction
Upon infection, B lymphocytes undergo affinity maturation to optimize the antibody response to the specific pathogen. Point mutations are introduced in the variable regions of the antibody genes by somatic hypermutation (SH) in the germinal centers. In addition, antibody effector functions can also be changed by class switch recombination (CSR), which changes the expressed constant region exons of the immunoglobulin heavy chain (IgH). These antibody diversification processes are initiated by targeted DNA deaminations made by activation-induced cytidine deaminase (AID) (Chen and Wang, 2014; Fear, 2013; Stavnezer, 2011; Wang, 2013) . The activity of various DNA repair enzymes on the deaminations made by AID subsequently leads to mutations and deletions in the DNA (Chen and Wang, 2014; Fear, 2013; Stavnezer, 2011; Wang, 2013) . AID is highly regulated to permit SH and CSR of Ig genes while retaining genome integrity more widely (Chen and Wang, 2014; Fear, 2013; Kothapalli and Fugmann, 2011; Stavnezer, 2011; Wang, 2013) . This tight regulation of AID is critical since aberrant Abbreviations: CSR, class switch recombination; SH, Somatic hypermutation; AID, activation-induced cytidine deaminase; PLA, proximity ligation assay; BCR, Bcell receptor; CaM, calmodulin.
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expression of AID leads to increased mutagenesis at non-Ig sites in the genome and development of a wide range of tumours (Casellas et al., 2016; Morisawa et al., 2008; Okazaki et al., 2003) . Mechanistically, deamination by AID requires active transcription, and proteins associated with the transcription process or to splicing have been shown to interact with AID (Kothapalli and Fugmann, 2011; Stavnezer, 2011) . The ability to switch to specific isotypes by CSR depends on a complex, wide-ranging integration of signals resulting from activation of the B-cell receptor (BCR), cytokine receptors, Toll-like receptors, and tumor necrosis factor family members. Ultimately this leads to transcription of the switch region of the appropriate antibody class (Pone et al., 2010) . While this transcription is of critical importance for CSR to a particular isotype, the trans-acting factors mediating selective targeting of AID to antibody genes and therefore SH and CSR remain elusive (Chandra et al., 2015; Chen and Wang, 2014; Fear, 2013; Kothapalli and Fugmann, 2011; Stavnezer, 2011; Wang, 2013) . To date, the best candidate of AID targeting is the basic-helix-loop-helix (bHLH) class of transcription factors, since E-boxes, which most bHLH's bind, have been shown to be important in the AID mediated diversification process (Chen and Wang, 2014; Fear, 2013; Stavnezer, 2011; Tanaka et al., 2010; Wang, 2013) . However, while E-boxes have been implicated in targeting of AID, to date, no direct association between AID and any protein known to bind to E-boxes has been documented. Thus, how AID is recruited to its specific targets in antibody genes is still among the biggest mysteries in the field (Chandra et al., 2015; Chen and Wang, 2014; Fear, 2013; Kothapalli and Fugmann, 2011; Stavnezer, 2011; Wang, 2013) .
We have previously reported that Ca 2+ -loaded calmodulin (CaM) can inhibit the E-box binding basic-helix-loop-helix transcription factor E2A and that this inhibition is essential for certain important responses to activation of the membrane bound antibody of the BCR (Corneliussen et al., 1994; Hauser et al., 2008b Hauser et al., , 2009 Saarikettu et al., 2004; Verma-Gaur et al., 2012) . Mechanistically, Ca 2+ -loaded CaM inhibits E2A by binding as a dimer to the two DNA-binding basic sequences of the bHLH domain and thereby inhibits the binding of the transcription factor to E-box DNA (Larsson et al., 2005; Onions et al., 2000; Saarikettu et al., 2004) . Here we use the sensitivity of E2A to BCR activation as a tool to assess if E2A is important in CSR. We analyzed whether E2A is important in targeting of CSR by determining if mutation of E2A rendering it resistant to CaM changes BCR dependent CSR. The CaMresistant mutant (m8N47) carries substitution of three amino acids in the DNA binding basic sequence of the bHLH domain. This mutation of E2A inhibits CaM binding without inhibiting binding to DNA or to Id proteins (Hauser et al., 2008a,b) . We show that defective CaM inhibition of E2A leads to reduced BCR, IL4 plus CD40 ligandstimulated CSR to IgE and instead directs CSR to other Ig classes. We demonstrate that AID forms a complex together with the transcription factors E2A, PAX5 and IRF4 on key sequences of the Igh locus in activated mouse splenic B cells. Also CaM is in proximity with them after BCR stimulation. Upon BCR signaling, binding of the AID, E2A, PAX5 and IRF4 proteins to some of the target sites is reduced, and CaM resistance of E2A prevents these BCR stimulated reductions and instead increases binding to other target sites. We have previously reported a direct interaction between purified heterologously expressed E2A and PAX5 transcription factors in vitro . Here we show direct interactions between AID, the PD domain of PAX5 and the bHLH domain of E2A. Taken together, these data demonstrate that E2A, AID, PAX5 and IRF4 form a complex that is redistributed on the Igh locus upon BCR signaling. Mechanistically, this is achieved through CaM binding to E2A, therefore directing the specificity of CSR.
Materials and methods

Plasmids and viruses
The retrovirus encoding E12 splice form of E2A and C-terminally Flagged PAX5 has been described previously . For the AID and IRF4 constructs, the GFP-encoding DNA of the MSCV-IRES-GFP plasmid was replaced by oligonucleotides comprising a tandem repeat of the Flag epitope coding sequence (Saarikettu et al., 2004) and restriction enzyme sites for insertion of full-length cDNAs of AID and IRF4 obtained from GenScript. E12 wild-type and CaM-resistant mutant with or without the Cterminal Flag epitope were cloned into the MSCV-IRES constructs as described previously (Hauser et al., 2008b) . Production of retroviruses was in 293T packaging cells as previously described (Hauser et al., 2008b) .
Activation and infection of B-lymphocytes from mouse spleens
Primary B-lymphocytes were purified from mouse spleens and maintained as previously described (Hauser et al., 2008b) and stimulated with 5 ng/ml IL-4 (Pepro-Tech) and 50 ng/ml CD40L (R&D Systems). The BCR of stimulated cells at 10 6 cells/ml, or where indicated at 2 × 10 5 cells/ml, was (where indicated) activated by incubation with goat F(ab') 2 anti-mouse IgM (Southern Biotechnologies) at 2.5 g/ml for the indicated times. Retrovirus concentrated by centrifugation was added with 5 g/ml polybrene to 0.5 × 10 6 purified B cells after activation with CD40L plus IL-4 for 24 h. After 12 h incubation, the infection was repeated for 12 h, followed by incubation for a further 22 h post-infection in fresh complete medium with the stimulants to allow for expression of E12, AID, PAX5, IRF4 and/or GFP. The medium was supplemented with a minimal 0.2 g/ml of LPS (Calbiochem), i.e. more than 100 times less LPS than usually used in LPS-driven CSR studies, during retroviral infection incubations to enable infection. Where indicated, anti-mouse IgM was added for the indicated times.
FACS analysis
Immunostaining of harvested cells to analyze class switching was performed on cells fixed with 2% paraformaldehyde and permeabilized with 0.5% saponin using the following antibodies: anti-IgM-PE-Cy7, anti-IgD-PE and anti-IgG1 from BD Pharmingen, anti-IgG3 and anti-IgG2b from BioLegend, anti-IgA-PE from eBioscience, and anti-IgG2c and anti-IgE from Southern Biotech. When using primary antibody biotinylated using an antibody biotinylation kit (Miltenyi Biotech), the secondary antibody was Streptavidin-APC or Streptavidin-PerCP from BioLegend. Antirat-PE and anti-goat-APC were from Jackson ImmunoResearch. Stainings were for 30 min at RT in the dark. Flow Cytometry was with a FACSCalibur instrument and analysis was with CellQuest software (Becton Dickinson Biosciences).
Proximity ligation assay
Harvested B-lymphocytes were fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, cytospun, and blocked with 5% FCS in PBS. Proximity ligation assay (PLA) Söderberg et al., 2006 Söderberg et al., , 2008 Söderberg et al., , 2007 was performed with the Duolink system using in situ PLA kits from Olink Biosciences. In brief, cells were labelled with antibodies raised against intracellular proteins (antibodies listed in Supplementary Table 1) . Secondary antibodies conjugated with oligonucleotides (PLA probes) were subsequently used according to the manufacturer's protocol to generate fluorescence signals only when the two PLA probes were in close proximity (≤40 nm). The fluorescence signal from each detected pair of PLA probes was visualized as a distinct individual red dot in a Nikon 90i epifluorescence microscope. The antibodies were used at dilutions that yielded a low number of dots/cell to reduce the risk of missing dots in the quantifications. Nuclei were counterstained with Hoechst 33342 dye. To enhance detection of infected cells, anti-GFP-FITC antibody (Novus biologicals) was added during the PLA signal-detection step. The AID and PAX5 antibodies were used after biotinylation with an antibody biotinylation kit (Miltenyi Biotech) where necessary.
Chromatin immunoprecipitation
Purified and infected primary splenic B-cells from mice heterozygous for knockout of the E2A gene (Zhuang et al., 1994) were cross-linked with 1% formaldehyde for 10 min at room temperature. Cross-linking was quenched by adding glycine to 120 mM, and cells were washed with Phosphate-buffered saline. Cells were lysed on ice with 0.25 ml of RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, and 5 mM EDTA) supplemented with protease inhibitor mixture (Roche Applied Science). The lysate was sonicated at 60% amplitude for 10 times 10 s on a VibraCell instrument (Sonics), giving an average size of sheared chromatin fragments of 180 bp, and clarified by centrifugation. 5 l was saved as input, and the lysate was incubated overnight at 4 • C with anti-Flag-tag antibody (anti-DYKDDDDKtag) (GenScript). Immunocomplexes were bound for 1 h to 20 l of magnetic Dynabeads-Protein A (Invitrogen) at 4 • C. Beads were washed three times with RIPA buffer and three times with Tris-EDTA, pH 8.0, on a magnet (Invitrogen). Cross-links were reversed with 1% SDS in Tris-EDTA, pH 8.0, at 65 • C overnight, and samples were treated with Proteinase K (20 g/ml) for 1 h at 45 • C. DNA was phenol-chloroform extracted, ethanol-precipitated, and analyzed by real-time PCR. The Real-time PCR analysis was performed as previously described using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as internal control (Hauser et al., 2008b) and each sample was quantified relative to its input chromatin DNA. The specificity of the Real-time PCR was analyzed by melt-curve analysis as described by the manufacturer. The Real-time PCR primer pairs used are listed in Supplementary Table 1 . The E and hs3b primers were from (Greenbaum and Zhuang, 2002) , the V1, V11, V13, V H 7183, V H J558, C and C␦ primers were from (Zhang et al., 2006) . The primers for hs5 and hRE1 were designed based on positive E2A ChIP signals in mature B cells within these amplicons in the 3 regulatory region of Igh (Lin et al., 2010) . The switch region primers were designed based on sequences found to be mutagenized in class switching of s (Rajagopal et al., 2009; Xue et al., 2006) , and S␥1, S␥2b, S␥2c, S␥3, S␣ and S (Rajagopal et al., 2009; Xue et al., 2006) .
Protein expression and binding assay
The expression of full-length murine PAX5 and amino acids 431-652 of murine E12 in E. coli BL21(DE3)pLysS and the purification of the proteins have been described previously . Expression plasmids for the E12 derivatives with deletion of the bHLH domain, the sequences N-terminal or C-terminal to the bHLH domain, or deletion of everything except the bHLH domain, and the PAX5 derivatives with deletion of the paired domain, the homeodomain or everything C-terminal to the homeodomain or C-terminal to amino acid 176 (Fig. 7F) were purchased from GenScript. The deletion derivatives were expressed and purified as previously described for full-length PAX5 and the E12 . E. coli-produced CaM was purchased from Millipore. The cDNA for full-length murine AID was obtained from Genscript and subcloned into pET21b+ (2), a derivative of pET21b+ (Novagen) where the N-terminal T7-tag is replaced with the pelB leader from pET20b+ (Novagen). The His 6 -tagged protein was expressed in E. coli BL21(DE3)pLysS. AID expressing cells were centrifuged and lysed by sonication in 50 mM Sodium phosphate, pH 8.0, 300 mM NaCl, 2 mM MgCl 2 , 0.5 mM DTT, 1 mM PMSF. Urea was added to 8 M and AID was purified by Ni-NTA agarose chromatography (Qiagen) according to the manufacturer's instructions. The AID was eluted with 100 mM Sodium phosphate, 10 mM Tris, pH 4.5, 8 M Urea and dialysed against 6 M Guanidine, 40 mM DTT. Purified AID was then renatured by addition of 20 vol of 1% myristylsulfobetanaine (surfactant SB3-14; TaKaRa) and dialysis against 75 mM Sodium phosphate, pH 8.0, 68 mM NaCl, 0.7% Sarkozyl, 15% Glycerol, 0.3 M Arginine. Purified AID and the E12 were dialysed against 0.1 M Sodium phosphate, 0.5 M NaCl (pH 8.0) and coupled to CNBr-activated Sepharose 4 B (GE Healthcare) following the manufacturer's instructions and using 0.1 M Sodium phosphate, 0.5 M NaCl, pH 8.0, as coupling buffer. Purified PAX5 were coupled to CNBr-activated Sepharose 4 B as previously described . Purified E12, PAX and deletion derivatives of these (0.2 g) were incubated with 10 l AID-Sepharose, E12-Sepharose, PAX5-Sepharose or control Sepharose beads as indicated in a binding buffer containing 50 mM Tris-HCl, pH 8, 100 mM NaCl, 1.5% Triton X-100, 1 mM DTT and protease inhibitor cocktail tablet without EDTA (Roche) and 0.1 mM EGTA with rotation for 30 min at room temperature. 0.1 mM CaCl 2 was used instead of the chelator in the indicated lane of Fig. 7C . The AID-Sepharose, E12-Sepharose, PAX5-Sepharose and control Sepharose were washed twice with binding buffer and bound proteins were eluted by boiling in Laemmli loading buffer. Samples were separated by SDS-PAGE and analyzed by western blot using Tetra-His antibody (Roche) for E. coli-produced E12, PAX5 and deletion derivatives of these and with CaM antibody (EP799Y; Novus Biologicals) for E. coli-produced CaM.
Statistical analysis
All experiments were performed at least three times. All data are expressed as means ± SD. The results were analyzed using the Student's t-test with two-tailed distribution. Significant P values are shown at *P < 0.05, **P < 0.01, or ***P < 0.001.
Results
CaM resistance of E2A reduces BCR stimulated CSR to IgE and instead directs CSR to other ig classes
To analyze whether E2A has a role in controlling CSR, we infected splenic mouse B cells with retrovirus expressing green fluorescent protein (GFP) plus either wild type or CaM-resistant E12 splice form of E2A. We have systematically found in previous studies that CaM-resistant E12 protein is dominant over all endogenous CaMsensitive E2A, i.e. both proteins containing the E12 splice form and the E47 splice form (Corneliussen et al., 1994; Hauser et al., 2014 Hauser et al., , 2008a Hauser et al., ,b, 2013 Hauser et al., , 2009 Hauser et al., , 2010 Saarikettu et al., 2004; Verma-Gaur et al., 2012; Wallenius et al., 2014) . This is as expected, since dimers between a sensitive and a resistant E2A lack half of the calmodulin interaction sites and therefore will be essentially resistant. Mice homozygous for knock-out of E2A could not be used to assess the role of E2A in CSR since such mice have blocked B cell development and lack a spleen (Bain et al., 1994; Zhuang et al., 1994) . To reduce background from endogenous CaM-sensitive E2A, B-cells from mice heterozygous for knock-out of the E2A gene (Zhuang et al., 1994) were used instead. Intracellular FACS staining for E2A showed that the expression level of E2A was similar to endogenous wild type E2A levels (less than two fold difference) in the vast majority of infected splenic B-cells. This observation is consistent with data from pre-B cells infected with these constructs reported in a previous study . CSRs occur during the G1 phase of the cell cycle in cells that are rapidly dividing (Hodgkin et al., 1996; Schrader et al., 2007; Sharbeen et al., 2012; Stavnezer et al., 2010) . To ensure that the analysis included conditions that facilitated fast growth, we seeded the cells at two different densities, 10 6 /ml and 2 × 10 5 /ml. The cells were activated with IL-4 and CD40 ligand (CD40L), a key activating cytokine from T helper cells, that together induce CSR predominantly to IgG1 but also to IgE (Pone et al., 2010) . The cells were given a time-limited treatment with a low amount of LPS (0.2 g/ml) during the retroviral infection incubation step to enable infection, and permeabilized cells were labelled to enable measurement of cytoplasmic antibodies and FACS analysis was performed. Under these conditions, many cells had class-switched from IgM and IgD to IgG1 or IgE after 4 days both for cells infected with retrovirus expressing wild type E12 and CaM resistant E12 as well as the vector control retrovirus (Fig. 1A-B and Supplementary Fig. 1A ). As previously reported (Hauser et al., 2009) , stimulation of the BCR after 2 days increased the number of large cells at day 4 ( Supplementary Fig. 1A ). It also led to a strong reduction in cells expressing IgM or IgD both among cells infected to express wild type E12 and cells infected with vector control retrovirus at both the higher and the lower cell density (Fig. 1A-B and Supplementary Fig. 1A ). As previously reported (Hauser et al., 2009 ), CaM-resistance of E12 reduced the shift away from expres- Significant P values for differences between wild-type and CaM-resistant E12 are shown at *P < 0.05, **P < 0.01, or ***P < 0.001. The FACS results from a representative experiment with the B lymphocytes of one mouse is shown in Supplementary A. sion of IgM and IgD upon BCR stimulation at both cell densities (Fig. 1A-B and Supplementary Fig. 1A) . Importantly, the frequency of IgE positive B cells was much lower when CD40L and IL-4 stimulation was combined with BCR stimulation for the CaM-resistant mutant than for wild-type E2A at both cell densities (Fig. 1A-B and Supplementary Fig. 1A ), whereas no significant difference between wild-type and mutant was seen for IgG1. The differences between wild-type and mutant in the percentage of gated cells after BCR stimulation were statistically significant at both cell densities for IgM, IgD and IgE (Fig. 1A-B and Supplementary Fig. 1A ). Thus, CaM resistance of E2A inhibited class-switching from IgM and IgD to IgE in the BCR stimulated B cells. We next measured the effect of the CaM resistance on class switching to the other Ig classes. The BCR stimulation had at both cell densities no significant effect on the frequency of cells positive for IgG2c but strongly reduced the frequency of cells positive for IgG2b, IgG3 and IgA (Fig. 1B) . Importantly, and in strong contrast, BCR stimulation did not reduce the fraction of the cells with CaM-resistant E12 that were positive for any of the IgG2b, IgG3 and IgA classes (Fig. 1B) . Taken together, this supports the notion that CaM resistance of E2A that inhibited appropriate CSR to IgE in CD40L, IL-4 plus BCR stimulated B cells at the same time blocked BCR-mediated reduction in CSR to IgG2b, IgG3 and IgA.
Since the effects of CaM resistance of E2A on CSR implied a possible coupling between E2A and the CSR-inducing mutagenic enzyme AID, we next examined whether over-expression of AID, which could lead to ectopic localization of AID in the locus, also could lead to changed CSRs. We infected B cells from spleens of mice heterozygous for knock-out of the E2A gene with retrovirus expressing both AID and wild type or CaM-resistant E12 from the same virus. Cells were immunostained with antibodies against both AID and the indicated Ig class. Cells with and without clear over-expression of AID were gated separately. In cells with moderate expression of AID and E2A from the virus, BCR stimulation reduced the frequency of cells expressing IgM, IgD, IgG3 and IgA, whereas the frequency of IgE expression increased (Supplementary Fig. 1B) . Interestingly, over-expression of AID resulted in a reduction in CSR to IgE and a corresponding increase in other CSRs similar to CaM-resistance of E2A (cf. Fig. 1B and Supplementary Fig. 1B) . Furthermore, the effects of over-expression of AID and of CaM-resistance of E2A were synergistic, leading to an enhanced phenotype greater than the effects of only expressing CaM-resistant E2A or over-expressing AID together with wild type E2A (Fig. 1B and Supplementary Fig.  1B ). In conclusion, both over-expression of AID and CaM-resistance of E2A changes CSR when combining the activation of the B-cells with BCR-stimulation.
AID is together with the transcription factors E2A, PAX5 and IRF4 in activated B cells
The related effects of either mutating E2A or over-expressing AID on CSR indicated a possible connection between E2A and AID in vivo. To analyze if E2A and AID were physically together, we performed proximity ligation assays (PLA) in situ using the Duolink system, which enables visualization and quantification of protein interactions by microscopy of cells. Mouse splenic B-cells grown with CD40L and IL-4 were labelled using antibodies against the two proteins and subsequently with PLA probes to generate fluorescence signals seen as distinct individual red dots when the two proteins were in close proximity (≤ 40 nm) Söderberg et al., 2006 Söderberg et al., , 2008 Söderberg et al., , 2007 . We observed specific proximity signals between AID and E2A, and the background signals were minimal when one or both of the primary antibodies were omitted ( Fig. 2A) . The proximity measurements between AID and E2A were observed with two independent AID antibodies confirming this finding. BCR stimulation transiently potentiated the proximity signal between AID and E2A by 2-fold to 3-fold in 30 min, and after 3 h the proximity returned to the level before BCR stimulation ( Fig. 2A and quantifications in Fig. 2B and Supplementary  Fig. 2A ). It has been previously shown that the transcription factor IRF4 is critical for CSR (Lu, 2008) and the PAX5 transcription factor is important at the Igh locus (Medvedovic et al., 2011) . Both PAX5 and IRF4 showed proximity with AID significantly over background ( Fig. 2B and Supplementary Fig. 2 ). BCR stimulation further increased the proximity between AID and PAX5 approximately 4-fold in 30 min, and after 3 h most of this increase had disappeared. In contrast, BCR stimulation reduced the proximity between AID and IRF4 after 30 min ( Fig. 2B and Supplementary Fig. 2 ). The specificity of the PLA signals was verified by omitting one or both of the primary antibodies and in several cases by using different antibodies against the same protein ( Fig. 2 and Supplementary Figs. 2 and 3) , and by comparing proximity signals in B cells used in this study with those in cells that do not express PAX5, IRF4 or AID. The background was minimal in several control PLAs of PAX5 and of IRF4 in cells lacking the probe-marked protein and also in AID PLAs in resting B-cells not stimulated to induce expression of AID ( Supplementary  Fig. 3C ). For the PAX5 and E2A antibodies used, we have previously shown that the PLA background is minimal in control cells lacking the protein . The proximity identified between AID and each of E2A, PAX5 and IRF4 prompted us to analyze proximity between these transcription factors. The PLA showed specific E2A-PAX5, E2A--IRF4 and PAX5-IRF4 proximity. BCR stimulation increased the E2A-PAX5, E2A--IRF4 and PAX5--IRF4 proximities 2-fold or more in 30 min, and after 3 h the proximity returned to close to the level before BCR stimulation (Fig. 2B and Supplementary Fig.  2 ). In summary, the PLAs show pair-wise proximity between each of AID, E2A, PAX5 and IRF4 in activated B cells, and BCR stimulation temporarily increased the levels of the proximities.
3.3. In vivo regulation of an AID complex with E2A, PAX5 and IRF4 through CaM inhibition of E2A
We also analyzed the proximity of AID, E2A, PAX5 and IRF4 with CaM, since CaM resistance of E2A affected the CSR (Fig. 1 and Supplementary Fig. 1 ). The proximities were at background before the BCR stimulation with the only exception that the PAX5-CaM pair was moderately increased over background for one of the CaM antibodies tested ( Supplementary Fig. 2C ). The findings that PLA pairs with CaM in almost all cases did not give significant PLA signals before stimulation of the BCR provides additional negative controls supporting the notion that the PLA did not give unspecific signals over background. BCR stimulation for 30 min increased the proximity of all protein pairs with CaM. Proximities clearly over background endured over extended time periods (3 h), albeit in most cases at a reduced level. AID-dependent phosphorylation of serine 14 of histone H2 B (H2B(Ser14P)) and trimethylation of lysine 4 of histone 3 (H3K4me3) at the Igh locus are coupled to SHM and CSR (Begum et al., 2012; Odegard et al., 2005; Stanlie et al., 2010) . We therefore analyzed whether there was proximity between the histone modifications H2B(Ser14P) and H3K4me3 and AID, E2A, PAX5 and IRF4. We observed proximity between both H2B(Ser14P) and H3K4me3 and each of AID, E2A, PAX5 and IRF4. Furthermore, as found above for AID and transcription factor proximities, BCR stimulation for 30 min increased these proximities ( Fig. 2C and Supplementary Fig. 2D-E) . Notably, BCR stimulation did not inhibit the proximity of E2A, AID, PAX5 or IRF4 with H2B(Ser14P)-and H3K4me3-containing chromatin ( Fig. 2C and Supplementary Fig.  2D -E) despite that the Ca 2+ signal after BCR stimulation makes CaM inhibit the DNA binding of E2A (Corneliussen et al., 1994; Hauser et al., 2008b Hauser et al., , 2009 Larsson et al., 2005; Onions et al., 2000; Saarikettu et al., 2004; Verma-Gaur et al., 2012) . This finding indicates that when the stimulation induces CaM to bind to and inhibit DNA binding of E2A, then E2A stays at the chromatin through a direct or indirect interaction of AID, PAX5, IRF4 or another protein(s).
Next we analyzed the dependence of the protein proximities on the CaM-sensitivity of E2A. B cells from spleens of mice heterozygous for knock-out of the E2A gene were infected with retrovirus expressing wild-type or CaM-resistant E12 together with GFP to identify the infected cells. The increases in E2A-PAX5 and E2A-IRF4 proximities after 30 min of BCR stimulation were all blocked by CaM-resistant E12, whereas the increases in PAX5-IRF4, AID-E2A and AID-PAX5 proximities remained with CaM-resistant E12 (Fig. 3A and Supplementary Fig. 4A ). In contrast to the wild-type E12, when E12 was CaM-resistant the PAX5-IRF4, AID-E2A and AID-PAX5 proximities that were induced after 30 min of BCR stimulation were not reduced in the mutant after 3 h (Fig. 3A and Supplementary Fig. 4A ). This latter difference is probably through the previously reported (Hauser et al., 2008b (Hauser et al., , 2009 ) reductions in AID and PAX5 expression after CaM inhibition of E2A. The induction by BCR stimulation of proximity of E2A with CaM was almost completely blocked in the CaM-resistant mutant ( Fig. 3B and Supplementary Fig. 4B ). The remaining small increases could be due to not complete CaM resistance of the mutant (Hauser et al., 2008a (Hauser et al., , 2008b and to intermediately sensitive dimers, and perhaps higher multimers, between the CaM-resistant E12 and endogenous CaMsensitive E2A. The induction by BCR stimulation of the proximities of AID and IRF4 with CaM were also inhibited when E12 was CaMresistant ( Fig. 3B and Supplementary Fig. 4B ), which shows that these proximities are through the proximities of AID and IRF4 with E2A. However, the BCR stimulated increase in proximity between PAX5 and CaM was not blocked by CaM-resistant E12 (Fig. 3B and Supplementary Fig. 4B ), indicating that these two proteins can come in proximity through an E12-independent mechanism. The increases in proximities of AID, E2A, PAX5 and IRF4 with H2B(Ser14P)-containing and H3K4me3-containing chromatin after 30 min of BCR stimulation were all unaffected by CaM-resistance of E12, showing that they occurred through another mechanism. The reductions of these proximities after 3 h were instead blocked by CaM-resistant E12 (Fig. 3C and Supplementary Fig. 4C-D) , showing that these reductions are through CaM inhibition of E2A. Taken together, these data suggest the existence of a protein complex during class-switching consisting of at least AID, E2A, PAX5 and IRF4 at H2B(Ser14P)-and H3K4me3-containing chromatin that remains when CaM binds to the complex after BCR stimulation.
Localization of a complex of AID, E2A, PAX5 and IRF4 at the Igh locus is affected by CaM inhibition of E2A
To analyze the effects of CaM resistance of E12 on the localization of E12, AID, PAX5 and IRF4 in vivo, we performed chromatin immunoprecipitation (ChIP) before and after BCR stimulation using splenic B cells of mice heterozygous for knock-out of the E2A gene. The cells were infected with retrovirus expressing E12 with a C-terminal tandem Flag epitope, and the ChIP was against the Flagtag. The recovered DNA was analyzed by quantitative real-time PCR using primer pairs amplifying regions of the Igh locus containing target sites for E2A (E-box sequences), PAX5, and AID, and the transcribed C and C␦ parts of the locus. Some of the amplicons with E2A, PAX5 or AID sites also have an IRF4 site. For the E-boxcontaining Igh enhancers E and hs3b (Greenbaum and Zhuang, 2002) , we observed as expected Flag ChIP signals in cells expressing E12 over the background of cells infected with empty vector (Fig. 4A) . In cells expressing E12 we also observed Flag ChIP signals significantly higher than the background of cells infected with empty vector for the hs5 and hRE1 amplicons in the 3 regulatory region of Igh that also contains sites of positive E2A ChIP signals in mature B cells (Lin et al., 2010) . The hs3a and hs4 amplicons did not result in signals enough over vector background to give meaningful data and were therefore not included. Several nucleotides in addition to the canonical E-box sequence CANNTG are important for binding of E2A, and the genome has only a few in vivo E2A binding sites/million bp (Lin et al., 2010) . Nevertheless, we observed anti-Flag signals for E12-Flag far over the vector background also for almost all amplicons containing AID or PAX5 target sequences but not for control sequences from the C and C␦ regions of the gene, which do not contain a target sequence for E2A, AID, IRF4 or PAX5. Thus, E2A binds not only to E2A sites but also to many PAX5, IRF4 and AID sequences. This supports the existence of a complex between E2A, AID, IRF4 and PAX5 on the Igh locus. To further examine potential interactions between E2A, AID, IRF4 and PAX5, we next infected with retrovirus expressing non-tagged E12 together with either AID-Flag, PAX5-Flag or IRF4-Flag. As expected, we observed anti-Flag signals over the background of empty virus in the ChIP for target sequences of AID, PAX5 and IRF4, respectively (Fig. 4B-D) . Importantly, we observed for all three Flagged proteins also signals far over the background for all amplicons that had a target sequence for any one of the three other proteins of the complex that were without a Flag (Fig. 4B-D) . The anti-Flag signals were much weaker for control sequences from the C and C␦ for all four viruses (Fig. 4A-D) . These data strongly support the notion that E12, AID, PAX5 and IRF4 interact in vivo in a complex at the Igh locus through the DNA target sequences of these proteins.
To analyze the role of CaM inhibition of E2A in the effects of BCR stimulation on the E2A, AID, IRF4 and PAX5 protein complex, we infected the B cells with retrovirus expressing either wild-type or CaM-resistant E12 and performed anti-Flag ChIP before and after BCR stimulation for 30 min or 2 h (Fig. 5) . Since the V H J558 site from analysis with the E12-Flag virus did not result in signal clearly over the background (Fig. 4A) , we excluded it from our analysis. BCR stimulation for 30 min reduced the ChIP signal with anti-Flag between 2-fold and 8-fold in cells infected with the retrovirus expressing wild-type E12-Flag for all amplicons with E2A, AID or PAX5 target sequence that do not contain an IRF4 target site. This reduction remained after 2 h (Fig. 5A) . Thus, the binding of E2A to the Igh locus is rapidly reduced upon BCR stimulation both on E2A binding sites and on target sequences for AID and PAX5 where the localization of E2A must be indirect. In contrast, with amplicons containing IRF4 target sites, the anti-Flag ChIP signal showed very little or no reduction, independent of the presence of an E2A, AID or PAX5 target sequence (Fig. 5A) . Importantly, the reductions in anti-Flag ChIP signals for the amplicons with E2A, PAX5 or AID sequences that do not contain an IRF4 target site were all abolished by the expression of CaM-resistant E12-Flag after both 30 min and 2 h of BCR stimulation (Fig. 5A) . In contrast, at the sites that contain an IRF4 target, 30 min or 2 h of BCR stimulation instead increased the ChIP signal 2-fold to 5-fold for the CaM-resistant E12 mutant (Fig. 5A ). These data suggest that the AID complex with E2A, PAX5 and IRF4 is partially changing location at the Igh locus upon BCR stimulation through CaM inhibition of E2A. Next we examined interactions using virus expressing wild-type or CaM-resistant E12 plus AID-Flag (Fig. 5B ), PAX5-Flag (Fig. 5C ) or IRF4-Flag (Fig. 5D) . BCR stimulation reduced the anti-Flag ChIP signal for each of the AID-Flag, PAX5-Flag and IRF4-Flag viruses that expressed wild-type E12 when the site did not contain an IRF4 target site, independent of the presence of an E2A, AID or PAX5 target site at the DNA segment. In all cases the ChIP signal was 2-fold to 3-fold reduced after both 30 min and 2 h (Fig. 5B-D) . In contrast, no reduction of the anti-Flag ChIP signal after BCR stimulation was observed for any one of the corresponding CaM-resistant viruses at any of these sites, except the E2A site in the hs3b enhancer where in some cases a partial reduction was observed. The anti-Flag ChIP signal stayed or was only relatively little reduced after BCR stimulation for the viruses expressing AID-Flag or PAX5-Flag together with wildtype E12 on the amplicons containing an IRF4 site (Fig. 5B-C) . In contrast, for the CaM-resistant E12-Flag virus, the anti-Flag ChIP signal increased significantly after BCR stimulation for the viruses expressing AID-Flag or PAX5-Flag together with CaM-resistant E12 on the amplicons containing an IRF4 site (Fig. 5B-C ). An exception to this was infection with viruses expressing IRF4-Flag, since there was relatively little difference in the anti-Flag ChIP signal between the IRF4-Flag viruses co-expressing wild-type E12 or CaM-resistant Fig. 4 . Chromatin immunoprecipitation analysis of AID, E2A, PAX5 and IRF4 at the Igh locus. Purified splenic B-cells of mice heterozygous for knock-out of the E2A gene were infected with empty retrovirus (vector) or viruses expressing E12-Flag (A), or E12 plus AID-Flag (B), E12 plus PAX5-Flag (C) or E12 plus IRF4-Flag (D) from the MSCV-IRES plasmid and subjected to chromatin immunoprecipitation using the Flag epitope of the tagged protein. The recovered DNA was analyzed by real-time quantitative PCR using primer pairs amplifying regions of the Igh locus containing target sites for E2A (E-box sequences), PAX5, IRF4 and AID, and transcribed C and C␦ parts of the Igh locus as indicated. The identical amount of DNA, in mass, was used in the analysis of all samples from the same mouse and all quantifications were from the early log phase of the PCR. Three mice were analyzed and all PCR measurements were performed in triplicate. The figure shows the amount of PCR product obtained for each site after immunoprecipitation with anti-Flag (expressed as per mille (‰) of the amount of PCR product before immunoprecipitation). All data are presented as mean ± s.d.
E12 for any of the amplicons containing an IRF4 site (Fig. 5D ). For four of these sites, the signal increased 1.5-fold to three-fold after BCR stimulation and on the fourth site, V1, the signal was relatively modestly affected by the stimulation. The reason for the exception is unknown. However, since this occurred only for IRF4 on amplicons with IRF4 sites, it indicates that the interaction of this particular protein to its own site in contrast to the other proteins can remain unaffected after BCR signaling activates CaM to block the DNA binding of E2A. In summary, the ChIP analysis provides evidence supporting a complex of AID, E2A, PAX5 and IRF4 at target sequences of these proteins in the Igh locus and that some complexes leave some of the target sites upon BCR stimulation when E12 is wild-type, whereas when E12 is CaM-resistant the complexes instead remain bound at these sites and accumulate at other target sites.
To further study whether the reduced CSR to IgE and the inappropriate CSRs to IgG2b, IgG3 and IgA in B-cells with CaM-resistant E12 were due to a shift in the localization of AID, E12, PAX5 and IRF4 at the Igh locus, we next analyzed binding of AID and the transcription factors to the switch regions in the locus after BCR stimulation by ChIP. We observed anti-Flag ChIP signals with AID-Flag over the vector background for the amplicons containing different switch regions (Fig. 6A) . Importantly, localization of AID at S, the switch region for IgE, was significantly lower in the cells expressing CaM-resistant E12 than for the wild-type (Fig. 6A) , which directly correlates with the reduced CSR to IgE in these cells (Fig. 1) . Conversely, localization of AID at the switch regions S␥2b, S␥2c, S␥3 and S␣ was higher in the cells expressing CaMresistant E12 than in the wild-type ( Fig. 6 ; P values <0.02 except for S␥3), which corresponds to the increased CSR to IgG2b, IgG2c, IgG3 and IgA in the mutant cells or when over-expressing AID ( Fig. 1 and Supplementary Fig. 1B) . Thus, the CaM-resistant mutant has a re-localization of AID between the different switch regions that directly correlates with the shift in CSR. We observed anti-Flag ChIP signals with each of E2A-Flag, PAX5-Flag and IRF4-Flag over the vector virus background for the amplicons containing different switch regions (Fig. 6B-D) . Localization of each of E12, PAX5 and IRF4 was also significantly lower at the switch region S in the cells expressing CaM-resistant E12 than the wild-type (Fig. 6) , which directly correlates with the reduced CSR to IgE ( Fig. 1 and Supplementary Fig. 1A) . Conversely, for all three viruses localization of E12, PAX5 and IRF4 was at vector background or close to it for S␥2b, S␥2c, S␥3 and S␣ in cells expressing wild-type E12. These localizations were all higher in the cells expressing CaM-resistant E12 than in the wild-type ( Fig. 6; all P values <0.05, except 0.07 for S␣ with IRF4-Flag), which corresponds to the increased CSR to Fig. 5 . CaM inhibition of E2A participates in redistribution of AID, E2A, PAX5 and IRF4 at the Igh locus after BCR stimulation. Purified splenic B-cells of mice heterozygous for knock-out of the E2A gene were infected with retrovirus constructs as in Fig. 4 using either wild-type (WT) or CaM-resistant (CaM R ) E12. Infected cells were BCR-stimulated with anti-IgM for the indicated times and then subjected to chromatin immunoprecipitation using the Flag-epitope of the tagged protein and analyzed by quantitative PCR as in Fig. 4 . The Flag-tagged protein was (A) E12, (B) AID, (C) PAX5 and (D) IRF4. The figure shows the amount of PCR product obtained for each site after immunoprecipitation with anti-Flag compared with the amount of PCR product before immunoprecipitation. These values for anti-Flag-immunoprecipitated DNA are expressed relative to the immunoprecipitated DNA from the corresponding unstimulated cells expressing either WT or CaM R E12 that were set as 100% and indicated as a dotted line (bars not shown). All data are presented as mean ± s.d. based on three different mice. Significant P values for differences between wild-type and CaM-resistant E12 are shown at *P < 0.05, **P < 0.01, or ***P < 0.001. Some of the PCR amplified segments are in addition to sites for either E2A, AID or PAX5 also sites for IRF4 as indicated.
these classes (Fig. 1) . In summary, the CD40L, IL-4 plus BCR stimulated CaM-resistant mutant has a re-localization of each of AID, E2A, PAX5 and IRF4 from S to other switch regions that directly correlates with the shift in class-switching between these Ig classes in the mutant.
Direct interactions between AID, the PD domain of PAX5 and the bHLH domain of E2A
To analyze whether AID could interact directly with a protein in the identified complex, we next determined if purified recombinant E12 splice form of E2A (C-terminal 222 amino acids) and full-length recombinant PAX5 and CaM expressed in E. coli bound to purified recombinant full-length AID. PAX5 bound efficiently to AID Sepharose beads but not to control Sepharose beads with Protein A or without coupled protein (Fig. 7A) . Analysis of deletion derivatives revealed that the AID binding was in the Paired homology Domain (PD) of PAX5, since all deletion derivatives of PAX5 with the PD domain reproducibly bound efficiently to the AID beads, whereas PAX5 with deletion of only the PD domain reproducible showed no binding over the background (Fig. 7A and F) . E12 bound clearly less than PAX5 to the AID beads but it bound more than to the background control beads without coupled protein or with Protein A (Fig. 7B) . E12 bound to the AID beads through its bHLH domain, since E12 lacking the bHLH domain reproducibly showed no binding over the background, whereas the bHLH domain alone was sufficient for binding to the AID beads ( Fig. 7B and  F) . Notably, E12 lacking the part N-terminal to the bHLH domain reproducibly bound much more than wild type E12 to the AID beads, approximately as much as PAX5 to the AID beads. Thus, sequences N-terminal to the bHLH domain act negatively in the binding of the bHLH domain to AID. CaM showed no binding to the AID beads neither in the absence nor in the presence of Ca 2+ (Fig. 7C) . The interaction of AID with the PD domain of PAX5 and the bHLH domain of E12 was specific and does not represent an unspecific "stickiness" of our AID beads, since three proteins, CaM, PAX5 without PD domain and E12 without bHLH domain, did not bind.
To localize the direct interaction between PAX5 and E2A that we have reported previously , we analyzed the interaction of the deletion derivatives of E12 with PAX5 beads and the interaction of the deletion derivatives of PAX5 with E12 beads. PAX5 bound to E12 with the PD domain, since all deletion derivatives of PAX5 with the PD domain reproducibly bound efficiently to the E12 beads, whereas PAX5 with deletion of only the PD domain reproducibly showed no binding over the background (Fig. 7D, F and G). E12 bound to PAX5 with the bHLH domain, since E12 lacking the bHLH domain reproducibly showed no binding over the background, whereas the bHLH domain alone was sufficient for binding to the PAX5 beads (Fig. 7E, F and G) . In summary, AID can interact directly with the PD domain of PAX5 and with the bHLH domain of E2A, and PAX5 and E2A can interact directly with each other through the same domains (Fig. 7G ).
Discussion
CSR to the appropriate isotype depends on the extensive integration of signals from the BCR, cytokine receptors, Toll-like receptors, and tumor necrosis factor family members (Pone et al., 2010) . However, the trans-acting factors mediating specific targeting of AID to antibody genes and appropriate segments of them and therefore SH and the appropriate CSR have remained elusive (Chen and Wang, 2014; Fear, 2013; Kothapalli and Fugmann, 2011; Stavnezer, 2011; Wang, 2013) . To date, no direct coupling between any gene regulatory transcription factor and the targeting of AID has been previously demonstrated. In this study we showed that defective CaM inhibition of E2A reduced CD40L, IL-4 plus BCR stimulated CSR to IgE and instead increased CSR to other Ig classes. Furthermore, we found that AID and the transcription factors E2A, PAX5 and IRF4 were in a complex that is redistributed on the Igh locus upon BCR signaling through CaM binding. Is this a CSR complex and/or an SH complex? In support of a potential role in CSR we found a shift in physical localisation of AID, E2A, PAX5 and IRF4 when E2A was CaM-resistant from the usually used switch sequences of IgE towards localisation at the switch sequences used in the other CSRs. This strongly argues that this protein complex directs CSR to the appropriate classes. Is it also used in directing SH? Several of the target sites where AID, E2A, PAX5 and IRF4 were localised (Fig. 5) have no known role in CSR but are rather at sites of SH or close to such sites. This favours the idea that this complex also directs the SH. It is hard to envisage a separate set of transcription factors directing SH, since E2A, PAX5 and IRF4 are already all known key transcription factors in creating the repertoire of antibodies by rearrangements of the Ig loci during B cell development (Johnson et al., 2009) . The identification of a complex of AID with E2A, PAX5 and IRF4 in directing CSR and presumably also SH does however not imply that these are the sole gene-regulatory transcription factors involved.
The finding that each of AID, E2A, PAX5 and IRF4 could be immunoprecipitated with target sites for each of the others in ChIP (Figs. 4 and 5) argues that the proximities between these proteins shown in the PLA are due to interactions between the proteins. Furthermore, the effects of the CaM resistance mutation of E12 on the level of this co-immunoprecipitation, even when AID sites are analyzed with PAX5 or IRF4 and when PAX5 binding sites are analyzed with AID or IRF4, further supports the notion that all four proteins are in a complex together on the Igh locus. We have previously reported direct interaction between E2A and PAX5 and between E2A and CaM (Corneliussen et al., 1994; Hauser et al., 2008b Hauser et al., , 2009 Saarikettu et al., 2004; Verma-Gaur et al., 2012) , whereas direct interaction between any of the other proteins had not been previously reported. The findings that the proximities between most of these protein pairs, and between CaM and IRF4 or AID, are influenced when E2A is CaM-resistant (Fig. 3) suggests direct contact between at least some of AID, IRF4, PAX5 and E2A. Here AID was shown to interact directly with both PAX5 and E2A (Fig. 7) . This finding does not exclude that there also are interactions between these proteins through another protein in the complex. This is likely considering that other proteins coupled to the transcription process or to splicing also interact with AID and are required for the deamination (Kothapalli and Fugmann, 2011; Stavnezer, 2011) . We showed that AID interacts directly with the PD domain of PAX5 and with the bHLH domain of E2A (Fig. 7A, B , F and G) . Notably, the interaction with AID was much stronger for E12 with deletion of the sequences N-terminal to the bHLH domain than for E12 having these sequences. This indicates a possible regulatory mechanism that the E12-AID interaction might be negatively regulated by the N-terminal domain unless an appropriate protein interaction(s) impedes this inhibition of the interaction. That interaction(s) impeding the inhibition could be by a protein(s) participating in the activation of expression of immunoglobulins, but at present the identity of such a protein remains to be elucidated.
What is the biological significance of the AID/E2A/PAX5/IRF4 complex changing physical location at the Igh locus after BCR stimulation? A strong stimulation of the membrane-bound antibody of the BCR indicates to the cell that SH was successful and should be arrested. This signal has been shown to shut-off AID expression (Hauser et al., 2008b) . In contrast to SH, such BCR stimulation increases CSR (Fig. 1A, B) . It is therefore not surprising that the appropriate localization of the AID/E2A/PAX5/IRF4 complex on the Igh locus is different before and after BCR stimulation. It is notable that AID, IRF4, PAX5 and E2A were all found to be in physical contact with many dispersed segments of the Igh chromatin distributing over most of the locus, which would require extensive DNA looping. This is reminiscent of the state of the Igh locus when the gene is rearranged to create the repertoire of antibodies during B cell development. When Igh is accessible for the recombination machinery, chromosomal contraction and DNA looping enables recombination, whereas chromosomal expansion inhibits the recombination events (Bolland et al., 2009; Roldan et al., 2005) . During RAG-mediated recombination, the chromatin of the locus is organized in compartments containing clusters of loops separated by linkers, and the entire repertoire of variable regions merge and juxtapose to other DNA elements of the gene (Jhunjhunwala et al., 2008 (Jhunjhunwala et al., , 2009 . The large-scale chromatin structures reported (Bossen et al., 2012; Jhunjhunwala et al., 2008 Jhunjhunwala et al., , 2009 Medvedovic et al., 2013; Seitan et al., 2012; Stubbington and Corcoran, 2013) and the changes in them upon productive recombination indicate the existence of protein complexes binding to multiple places in Igh and thereby enabling looping between the critical DNA elements during that RAG-mediated recombination. The results presented here suggest that there are corresponding protein complexes during AID-mediated CSR and SH, and that these contain at least AID, E2A, PAX5 and IRF4.
BCR stimulation that leads to binding of Ca 2+ -loaded CaM to the AID/E2A/PAX5/IRF4 complex changed the distribution of the complex at the Igh locus. It is interesting in this context that the previously reported direct interaction between E2A and PAX5 in this study was found to be through the same domains as the interaction with AID, the PD domain of PAX5 and the bHLH domain of E2A (Fig. 7) . Thus, the DNA interacting PD domain of PAX5 also interacts with both AID and E12 and the DNA interacting bHLH domain of E2A interacts with each of CaM, AID and PAX5. Thus, it is easy to envisage that binding of CaM to the complex of the DNA binding PD and bHLH domains with AID could have an effect on the fine DNA binding preferences of one of the domains or both of them. The complex interactions between E2A, PAX5 and IRF4, their target sites on DNA, and AID and CaM and presumably other proteins in the complex and how they influence each other will be an important focus of further research.
